About HealthTech and Medicines KTN

The HealthTech and Medicines Knowledge Transfer Network (KTN) is built on the foundations of the original Health Technologies and bioProcessUK KTNs. The KTN supports business innovation through partnerships, funding and knowledge transfer:

• Connecting partners: Bringing together and facilitating collaborations with a common goal
  
  
• Access to funding: Identify and influence new and existing sources of funding
  
  
• Knowledge transfer: Opening doors to wider networks of people, organisations

bioProcessUK is a priority area within the HealthTech and Medicines KTN and is dedicated to advancing the UK biological medicines bioprocessing sector. Biopharmaceuticals (biological medicines) is the fastest growing sector in the pharmaceutical industry, accounting for 10% of the total drug sales and 30% of the products in the pipeline today. The UK has the second highest number of biopharmaceuticals in development worldwide.

The KTN is dedicated to the advancement of knowledge transfer and innovation within the key application areas of medicines, associated bioprocessing and health technologies (medical devices and diagnostics, including imaging) addressing needs across SME’s to large multinationals.

Reporting to the UK’s Technology Strategy Board (an executive non-governmental public body), Knowledge Transfer Networks are designed to improve the UK’s innovation performance by increasing the breadth and depth of knowledge transfer of technology into UK-based businesses and by accelerating the rate at which this process occurs.